Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-29 @ 1:28 PM
Study NCT ID:
NCT01514734
Status:
TERMINATED
Last Update Posted:
2013-10-21
First Post:
2012-01-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
Sponsor:
Alcon Research
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RDG-11-191
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None